The DOI matches its Crossref record; 252 of the 252 references it cites were found in a registry or an index.
Polyethylenimine (PEI) in gene therapy: Current status and clinical applications
Open accessAbstract
Polyethlyenimine (PEI) was introduced 1995 as a cationic polymer for nucleic acid delivery. PEI and its derivatives are extensively used in basic research and as reference formulations in the field of polymer-based gene delivery. Despite its widespread use, the number of clinical applications to date is limited. Thus, this review aims to consolidate the past applications of PEI in DNA delivery, elucidate the obstacles that hinder its transition to clinical use, and highlight potential prospects for novel iterations of PEI derivatives. The present review article is divided into three sections. The first section examines the mechanism of action employed by PEI, examining fundamental aspects of cellular delivery including uptake mechanisms, release from endosomes, and transport into the cell nucleus, along with potential strategies for enhancing these delivery phases. Moreover, an in-depth analysis is conducted concerning the mechanism underlying cellular toxicity, accompanied with approaches to overcome this major challenge. The second part is devoted to the in vivo performance of PEI and its application in various therapeutic indications. While systemic administration has proven to be challenging, alternative localized delivery routes hold promise, such as treatment of solid tumors, application as a vaccine, or serving as a therapeutic agent for pulmonary delivery. In the last section, the outcome of completed and ongoing clinical trials is summarized. Finally, an expert opinion is provided on the potential of PEI and its future applications. PEI-based formulations for nucleic acid delivery have a promising potential, it will be an important task for the years to come to introduce innovations that address PEI-associated shortcomings by introducing well-designed PEI formulations in combination with an appropriate route of administration.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 201–252 of 252
Dependence of PEI and PAMAM Gene Delivery on Clathrin- and Caveolin-Dependent Trafficking Pathways
Hwang, M. E., Keswani, R. K., & Pack, D. W. (2014) · Pharmaceutical Research · doi:10.1007/s11095-014-1598-6 · Cited by 50
Degradable Polyethylenimine-Based Gene Carriers for Cancer Therapy
Jiang, H., Islam, M. A., Xing, L., Firdous, J., Cao, W., He, Y., Zhu, Y., Cho, K., Li, H.-S., & Cho, C. (2017) · Topics in Current Chemistry · doi:10.1007/s41061-017-0124-9 · Cited by 49
Toy, R., Pradhan, P., Ramesh, V., Paolo, N. C. D., Lash, B., Liu, J., Blanchard, E. L., Pinelli, C. J., Santangelo, P. J., Shayakhmetov, D. M., et al. (2019) · Biomaterials · doi:10.1016/j.biomaterials.2019.119512 · Cited by 47
Cellular delivery of shRNA using aptamer-conjugated PLL-alkyl-PEI nanoparticles
Askarian, S., Abnous, K., Taghavi, S., Oskuee, R. K., & Ramezani, M. (2015) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2015.09.023 · Cited by 46
Anchordoquy, T. J., Armstrong, T., & Molina, M. D. C. (2005) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.20353 · Cited by 46
Factors influencing the nuclear targeting ability of nuclear localization signals
Sun, Y., Xian, L., Xing, H., Yu, J., Yang, Z. L., Yang, T., Yang, L., & Ding, P. (2016) · Journal of drug targeting · doi:10.1080/1061186x.2016.1184273 · Cited by 46
Sladek, F. M. (2003) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.7.5.679 · Cited by 45
Hsu, C. Y. M., Hendzel, M. J., & Uludağ, H. (2010) · The Journal of Gene Medicine · doi:10.1002/jgm.1526 · Cited by 43
Smart pH-sensitive nanoassemblies with cleavable PEGylation for tumor targeted drug delivery
Zhao, G., Long, L., Zhang, L., Peng, M., Cui, T., Wen, X., Zhou, X. W., Sun, L., & Che, L. (2017) · Scientific Reports · doi:10.1038/s41598-017-03111-2 · Cited by 43
Francis, S. M., Taylor, C. A., Tang, T., Liu, Z., Zheng, Q., Dondero, R. S., & Thompson, J. E. (2014) · Molecular Therapy · doi:10.1038/mt.2014.24 · Cited by 41
Histidine‐enhanced gene delivery systems: The state of the art
Hooshmand, S. E., Sabet, M. J., Hasanzadeh, A., Mousavi, S. M. K., Moghaddam, N. H., Hooshmand, S. A., Rabiee, N., Liu, Y., Hamblin, M. R., & Karimi, M. (2022) · The Journal of Gene Medicine · doi:10.1002/jgm.3415 · Cited by 41
Dextran-graft-linear poly(ethylene imine)s for gene delivery: Importance of the linking strategy
Ochrimenko, S., Vollrath, A., Tauhardt, L., Kempe, K., Schubert, S., Schubert, U. S., & Fischer, D. (2014) · Carbohydrate Polymers · doi:10.1016/j.carbpol.2014.07.048 · Cited by 40
Lin, C.-W., Jan, M., Kuo, J.-H. S., Hsu, L., & Lin, Y.-S. (2012) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2012.09.007 · Cited by 40
Hall, A., Parhamifar, L., Lange, M. K., Meyle, K. D., Sanderhoff, M., Andersen, H. B., Roursgaard, M., Larsen, A. K., Jensen, P. B., Christensen, C., et al. (2014) · Biochimica et Biophysica Acta (BBA) - Bioenergetics · doi:10.1016/j.bbabio.2014.12.002 · Cited by 39
Pfeifer, C., Hasenpusch, G., Üzgün, S., Aneja, M. K., Reinhardt, D., Kirch, J., Schneider, M., Claus, S., Frieß, W., & Rudolph, C. (2011) · Journal of Controlled Release · doi:10.1016/j.jconrel.2011.05.006 · Cited by 39
BMP2 gene delivery to bone mesenchymal stem cell by chitosan-g-PEI nonviral vector
Yue, J., Wu, J., Liu, D., Zhao, X., & Lu, W. W. (2015) · Nanoscale Research Letters · doi:10.1186/s11671-015-0906-3 · Cited by 39
Mannosylated Polyion Complexes for In Vivo Gene Delivery into CD11c+ Dendritic Cells
Raviv, L., Jaron‐Mendelson, M., & David, A. (2014) · Molecular Pharmaceutics · doi:10.1021/mp5005492 · Cited by 38
Parhiz, H., Hashemi, M., Hatefi, A., Shier, W. T., Farzad, S. A., & Ramezani, M. (2013) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2013.05.001 · Cited by 37
Liver‐targeted gene therapy: Approaches and challenges
Aravalli, R. N., Belcher, J. D., & Steer, C. J. (2015) · Liver Transplantation · doi:10.1002/lt.24122 · Cited by 37
Sheikhsaran, F., Sadeghpour, H., Khalvati, B., Entezar-Almahdi, E., & Dehshahri, A. (2016) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2016.11.008 · Cited by 37
Self-citationDevulapally, R., Lee, T., Bhargava-Shah, A., Sekar, T. V., Foygel, K., Bachawal, S. V., Willmann, J. K., & Paulmurugan, R. (2018) · Nanomedicine · doi:10.2217/nnm-2017-0328 · Cited by 37
Fang, G., Zeng, F., Yu, C., & Wu, S. (2014) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2014.07.007 · Cited by 35
Ma, K., Hu, M., Qi, Y., Qiu, L., Jin, Y., Yu, J., & Li, B. (2009) · Biomaterials · doi:10.1016/j.biomaterials.2009.03.042 · Cited by 34
Designer peptide delivery systems for gene therapy
Loughran, S. P., McCrudden, C. M., & McCarthy, H. O. (2015) · European Journal of Nanomedicine · doi:10.1515/ejnm-2014-0037 · Cited by 34
Interleukin-12 plasmid DNA delivery using l-thyroxine-conjugated polyethylenimine nanocarriers
Dehshahri, A., Sadeghpour, H., Oskuee, R. K., Fadaei, M., Sabahi, Z., Alhashemi, S. H., & Mohazabieh, E. (2014) · Journal of Nanoparticle Research · doi:10.1007/s11051-014-2423-1 · Cited by 34
Self-citationWu, P., Luo, X., Wu, H., Zhang, Q., Wang, K., Sun, M., & Oupický, D. (2020) · Bioconjugate Chemistry · doi:10.1021/acs.bioconjchem.9b00834 · Cited by 34
Novel poly(ethylene imine) biscarbamate conjugate as an efficient and nontoxic gene delivery system
Xu, S., Chen, M., Yao, Y., Zhang, Z., Jin, T., Huang, Y., & Zhu, H. (2008) · Journal of Controlled Release · doi:10.1016/j.jconrel.2008.04.025 · Cited by 33
Lee, Y. H., Park, H. I., & Choi, J. S. (2015) · Carbohydrate Polymers · doi:10.1016/j.carbpol.2015.10.089 · Cited by 31
Zhu, Q. X., ., W., Xu, Wang, Gao, Liu, K., & Liu (2012) · International Journal of Nanomedicine · doi:10.2147/ijn.s36179 · Cited by 30
High mobility group box 1 protein enhances polyethylenimine mediated gene delivery in vitro
Shen, Y., Peng, H., Deng, J., Wen, Y., Luo, X., Pan, S., Wu, C., & Feng, M. (2009) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2009.03.040 · Cited by 27
Middleton, M. R., Wermke, M., Calvo, E., Chartash, E., Zhou, H., Zhao, X., Niewel, M., Dobrenkov, K., & Moreno, V. (2018) · Annals of Oncology · doi:10.1093/annonc/mdy424.016 · Cited by 27
Kleemann, E., Jekel, N., Dailey, L. A., Roesler, S., Fink, L., Weißmann, N., SCHERMULY, R. T., Gessler, T., Schmehl, T., Roberts, C. J., et al. (2009) · Journal of drug targeting · doi:10.1080/10611860903106414 · Cited by 25
GEN-1 Immunotherapy for the Treatment of Ovarian Cancer
Thaker, P. H., Borys, N., Fewell, J. G., & Anwer, K. (2018) · Future Oncology · doi:10.2217/fon-2018-0423 · Cited by 24
Stegantseva, M. V., Shinkevich, V. A., Тумар, Е. М., et al. (2020) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-020-02652-2 · Cited by 24
Nicolle, L., Casper, J., Willimann, M., Journot, C. M. A., Detampel, P., Einfalt, T., Grisch‐Chan, H. M., Thöny, B., Gerber‐Lemaire, S., & Huwyler, J. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22083828 · Cited by 24
Self-citationYu, K., Suhua, W., & Li, H. (2015) · Journal of Experimental Nanoscience · doi:10.1080/17458080.2015.1029015 · Cited by 22
Dabbaghi, M., Oskuee, R. K., Hashemi, K., & Goli, A. A. (2017) · Artificial Cells Nanomedicine and Biotechnology · doi:10.1080/21691401.2017.1304406 · Cited by 22
Theoharis, S., Manunta, M., & Tan, P. (2007) · Expert Opinion on Biological Therapy · doi:10.1517/14712598.7.5.627 · Cited by 20
Casper, J., Nicolle, L., Willimann, M., Kuzucu, E. Ü., Tran, A., Robin, P., Detampel, P., Grisch‐Chan, H. M., Thöny, B., Huwyler, J., et al. (2022) · Macromolecular Bioscience · doi:10.1002/mabi.202200314 · Cited by 19
Self-citationSalmasi, Z., Mokhtarzadeh, A., Hashemi, M., Ebrahimian, M., Farzad, S. A., Parhiz, H., & Ramezani, M. (2018) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2018.09.028 · Cited by 18
Verstrepen, B. E., Oostermeijer, H., Fagrouch, Z. C., van Heteren, M., Niphuis, H., Haaksma, T., Kondova, I. I., Bogers, W. M. J. M., Filette, M. D., Sanders, N. N., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0112568 · Cited by 17
Dehshahri, A., Sadeghpour, H., Mohazabieh, E., Avval, S. S., & Mohammadinejad, R. (2020) · Biotechnology Progress · doi:10.1002/btpr.3002 · Cited by 16
Self-citationComplement Propriety and Conspiracy in Nanomedicine: Perspective and a Hypothesis
Moghimi, S. M. (2015) · Nucleic Acid Therapeutics · doi:10.1089/nat.2015.0587 · Cited by 15
Wu, T., Li, Z., Zhang, Y., Ji, J., Huang, Y., Yuan, H., Feng, F., & Schanze, K. S. (2018) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.8b07124 · Cited by 14
Albuquerque, T., Faria, R., Sousa, Â., Neves, A. R., Queiroz, J. A., & Costa, D. R. B. (2020) · Journal of Molecular Liquids · doi:10.1016/j.molliq.2020.113157 · Cited by 13
Microencapsulation of tumor lysates and live cell engineering with MIP-3α as an effective vaccine
Huang, F., Huang, F., Chen, B., Liu, Q., Wang, H., Zhou, S., Zhao, H., Huang, Y., Lin, Y., & Tan, G. (2015) · Biomaterials · doi:10.1016/j.biomaterials.2015.02.123 · Cited by 12
Current Advances in Vehicles for Brain Gene Delivery
Zhang, X., Zhao, L., Wu, J., Dong, H., Xu, F., Gong, G., & Hu, Y. (2012) · Current Gene Therapy · doi:10.2174/156652312802762590 · Cited by 11
Gene based therapies for kidney regeneration
Janssen, M. J., Arcolino, F. O., Schoor, P., Kok, R. J., & Mastrobattista, E. (2016) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2016.07.037 · Cited by 9
Partial Hepatectomy Enhances Polyethylenimine-Mediated Plasmid DNA Delivery
Tada, Y., Kitahara, T., Yoshioka, T., Nakamura, T., Ichikawa, N., Nakashima, M., Nishida, K., Nakamura, J., & Sasaki, H. (2006) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.29.1712 · Cited by 8
Askarian, S., Nasab, N. K., Aghaee‐Bakhtiari, S. H., Abadi, M. H. J. N., & Oskuee, R. K. (2022) · Molecular Biotechnology · doi:10.1007/s12033-022-00528-7 · Cited by 6
Maze, D., Pichon, C., & Midoux, P. (2023) · Gene Therapy · doi:10.1038/s41434-023-00386-1 · Cited by 6
Moreno, V., Gaudy‐Marqueste, C., Wermke, M., Italiano, A., Romano, E., Marabelle, A., Connors, E., Zhou, H., Dobrenkov, K., Chartash, E., et al. (2020) · Journal for ImmunoTherapy of Cancer · doi:10.1136/jitc-2020-sitc2020.0794 · Cited by 5
Cited by
Nanocarrier imaging at single-cell resolution across entire mouse bodies with deep learning
Luo, J., Molbay, M., Chen, Y., Horvath, I., Kadletz, K., Kick, B., Zhao, S., Al-Maskari, R., Singh, I., Ali, M., et al. (2025) · Nature Biotechnology · doi:10.1038/s41587-024-02528-1 · Cited by 53
Metadata
- Authors
- Casper, J., Schenk, S. H., Parhizkar, E., Detampel, P., Dehshahri, A., & Huwyler, J.
- Venue
- Journal of Controlled Release
- Publisher
- Elsevier BV
- Published
- 2023-10
- Volume
- 362
- Pages
- 667-691
- ISSN
- 0168-3659 (ISSN-L)
- OpenAlex
- W4386438765
- Cited by
- 340
- References
- 252
- FWCI
- 25.40
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.